← Back to Search

FDG PET/MRI for Colorectal Cancer

N/A
Waitlist Available
Led By Tyler Fraum, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months after completion of enrollment of all patients (26 months)
Awards & highlights

Study Summary

This trial is testing if a PET/MRI can be used to monitor rectal cancer in patients who are not having surgery. The results will help design future clinical trials for this purpose.

Eligible Conditions
  • Colorectal Cancer
  • Rectal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months after completion of enrollment of all patients (26 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months after completion of enrollment of all patients (26 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Technical Feasibility of PET/MRI as Measured by the Completion of the Study With Acceptable Image Quality in ≥70% of Scans
Secondary outcome measures
Percentage of Scans With Changes in Perceived Disease Status as Measured by PET/MRI Tumor Regression Grade Relative to the Conventional MRI Only Tumor Regression Grade

Trial Design

1Treatment groups
Experimental Treatment
Group I: FDG PET/MRIExperimental Treatment1 Intervention
-Patients will undergo FDG-PET/MRI in lieu of the standard pelvic MRI at up to 6 time-points at which it would normally be performed in their care for the period of time extending 30-36 months from the time of enrollment (depending on enrollment point). In the surveillance period, when patients typically undergo pelvic MRI every 3 months, the FDG-PET/MRI will be done in lieu of the standard pelvic MRI on an approximately every-other-scan basis. In other words, the FDG-PET/MRI will occur roughly once every 6 months.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,930 Previous Clinical Trials
2,298,971 Total Patients Enrolled
Tyler Fraum, M.D.Principal InvestigatorWashington University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for individuals to join this clinical experiment?

"Unfortunately, clinicaltrials.gov states that this medical experiment has concluded recruiting patients. It was first posted on June 1st 2020 and the last update occurred on December 21st 2021. Nonetheless, there are still 343 other trials actively seeking participants at the moment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
PET/MR for Rectal Cancer Treatment Monitoring and Surveillance
2020. "PET/MR for Rectal Cancer Treatment Monitoring and Surveillance". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04150705.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top